Moscow: There have been instances of infection among volunteers of Sputnik V trials, the world’s first registered vaccine against Covid-19 virus, according to a top official of the developer of the Russian vaccine, said a media report. This is the reason why the developer of the vaccine, the Gamaleya National Research Center for Epidemiology and […]
Moscow: Russia’s Sputnik V vaccine has shown 92 per cent efficacy in preventing COVID-19, according to interim trial results announced by the country’s health ministry on Wednesday. The announcement follows results unveiled earlier this week by vaccine developers Pfizer and BioNTech, who said their vaccine was more than 90 per cent effective at preventing COVID-19. […]
Moscow: Russia’s Sputnik V vaccine has been found to be more than 95 per cent effective against Covid-19 in the second interim analysis of Phase 3 clinical trial data, its developers said on Tuesday. The analysis was based on data from volunteers obtained 42 days after the first dose — which corresponds with 21 days […]
New Delhi: With the Drug Controller General of India (DCGI) approving Serum Institute of India’s ‘Covishield’ vaccine and Bharat Biotech’s ‘Covaxin’ for emergency use, paving way for their roll-out and administration to millions, Russian Sputnik V vaccine makers have said that they are working with AstraZeneca (AZ) to take the efficacy of AZ vaccine to […]
New Delhi: To cater to the vaccination process of the world’s largest democracy, it would be pertinent to bring in safer and more effective vaccines from other countries. However, on February 24, India’s drug authority had asked Dr Reddy’s, the Indian pharmaceutical company facilitating the trials in the country, to supply data on immunogenicity for […]
New Delhi: The Subject Expert Committee (SEC) of the Indian drug regulator, tasked with vetting Covid-19 vaccine proposals, sought additional data on Russian Covid-19 vaccine ‘Sputnik V’, while deciding on its emergency use authorisation, a senior government official said on Thursday. In September 2020, Dr. Reddy’s had partnered with the Russian Direct Investment Fund (RDIF) […]
New Delhi: After Sputnik V vaccines clinical trial’s preliminary results showed its efficacy at above 90 percent, the Russian Direct Investment Fund and Gamaleya Institute offered AstraZeneca the use of one of its two components in their own clinical trials. AstraZeneca accepted the proposal and will begin clinical trials of its vaccine in combination with […]
Moscow: India will produce about 300 million doses of the Russian Sputnik V COVID-19 vaccine in 2021, the head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said in an interview with a TV channel. “In India, we have agreements with four large manufacturers. …India will produce about 300 million doses or more of […]
Copyright © 2024 - Odisha Television Limited All Rights Reserved.